Anti-Colorectal Cancer Activity of Panax and Its Active Components, Ginsenosides: A Review
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26062593 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Han Su Kang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Republic of Korea. Hauptthemen laut MEDLINE: Ginsenosides, Colorectal Neoplasms, Panax, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korean Society of Ginseng.
Abstract (Originalsprache)
Colorectal cancer (CRC) poses a significant health burden worldwide and necessitates novel treatment approaches with fewer side effects than conventional chemotherapy. Many natural compounds have been tested as possible cancer treatments. Plants in the genus Panax have been widely studied due to their therapeutic potential for various diseases such as inflammatory disorders and cancers. Extracts from plants of genus Panax activate upstream signals, including those related to autophagy and the generation of reactive oxygen species, to induce intrinsic apoptosis in CRC cells. The root extract of Panax notoginseng (P. notoginseng) regulated the gut microbiota to enhance the T-cell-induced immune response against CRC. Protopanaxadiol (PPD)-type ginsenosides, especially Rh2, Rg3, Rb1, and Rb2, significantly reduced proliferation of CRC cells and tumor size in a xenograft mouse model, as well as targeting programmed death (PD)-1 to block the immune checkpoint of CRC cells. Moreover, modified nanocarriers with ginsenosides upregulated drug efficacy, showing that ginsenosides can also be utilized as drug carriers. An increasing body of studies has demonstrated the potential of the genus Panax in curing CRC. Ginsenosides are promising active compounds in the genus Panax, which can also support the activity of conventional cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Republic of Korea.
ORCID-Profile: Han Su Kang, Won Young Jang, Jae Youl Cho
Förderung
- Korean Society of Ginseng
Zitieren
APA
Kang, H. S., Lim, H. K., Jang, W. Y., & Cho, J. Y. (2025). Anti-Colorectal Cancer Activity of Panax and Its Active Components, Ginsenosides: A Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062593
Vancouver
Kang HS, Lim HK, Jang WY, Cho JY. Anti-Colorectal Cancer Activity of Panax and Its Active Components, Ginsenosides: A Review. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062593
BibTeX
@article{Kang2025,
author = {Kang, Han Su and Lim, Hyun Kyung and Jang, Won Young and Cho, Jae Youl},
title = {Anti-Colorectal Cancer Activity of Panax and Its Active Components, Ginsenosides: A Review},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26062593}
}
EUVIMED